Back to top
more

Merit Medical Systems (MMSI)

(Real Time Quote from BATS)

$73.97 USD

73.97
15,344

+0.19 (0.26%)

Updated Apr 29, 2024 10:56 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (95 out of 252)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Merit Medical (MMSI) Beats on Q2 Earnings, Raises Guidance

by Zacks Equity Research

Merit Medical (MMSI) gains from solid segmental performance in Q2; lifts 2018 guidance.

    AngioDynamics (ANGO) Q4 Performance Dull, Competition Rife

    by Zacks Equity Research

    AngioDynamics' (ANGO) fourth-quarter performance dull; stiff competition a serious concern.

      Merit Medical (MMSI) to Report Q2 Earnings: What's in Store?

      by Zacks Equity Research

      Merit Medical's (MMSI) acquisition-driven strategy to boost growth by expanding existing product offerings across all business segments in Q2.

        HSIC or MMSI: Which Is the Better Value Stock Right Now?

        by Zacks Equity Research

        HSIC vs. MMSI: Which Stock Is the Better Value Option?

          Zacks.com featured highlights include: Anthem, Merit Medical, Boston Scientific, Grand Canyon and PetMed

          by Zacks Equity Research

          Zacks.com featured highlights include: Anthem, Merit Medical, Boston Scientific, Grand Canyon and PetMed

            7 GARP Stocks to Scoop Up for Maximum Returns

            by Zacks Equity Research

            Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.

              Here's Why You Should Hold Merit Medical (MMSI) Stock Now

              by Zacks Equity Research

              Here we take a quick look at the major factors that plague Merit Medical (MMSI) and discuss the prospects that ensure near-term recovery.

                Merit Medical (MMSI) Up 18.9% in a Month on Solid Q1 Earnings

                by Zacks Equity Research

                Merit Medical (MMSI) reports strong Q1 earnings and sees solid growth across segments and geographies.

                  Zacks.com highlights: VMware, PetMed Express, Merit Medical Systems, Dollar General and inTEST

                  by Zacks Equity Research

                  Zacks.com highlights: VMware, PetMed Express, Merit Medical Systems, Dollar General and inTEST

                    Can High Revenues Aid SBA Communications (SBAC) Q1 Earnings?

                    by Zacks Equity Research

                    While higher consolidated revenues might benefit SBA Communications (SBAC) in Q1 earnings, its financials are likely to be affected by high customer concentration & consolidation in wireless industry.

                      Nokia (NOK) to Report Q1 Earnings: What's in the Cards?

                      by Zacks Equity Research

                      Higher revenues are likely to aid Nokia (NOK) to surpass earnings estimates in the to-be-reported quarter.

                        What to Expect From International Paper (IP) in Q1 Earnings?

                        by Zacks Equity Research

                        Despite contraction in gross estimated revenues figure, can International Paper (IP) beat market estimates in this quarter? Here are some clues for investors.

                          What Makes Patterson Companies (PDCO) a Strong Sell?

                          by Zacks Equity Research

                          Patterson Companies (PDCO) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

                            Becton, Dickinson (BDX), Bard Receive Regulatory Nod in China

                            by Zacks Equity Research

                            Favorable tidings on the regulatory front have boosted Becton, Dickinson and Company (BDX) lately. After the closure of the deal, the company will establish a new business segment.

                              Is a Beat in Store for Walgreens Boots (WBA) in Q1 Earnings?

                              by Zacks Equity Research

                              Walgreens Boots' (WBA) Retail Pharmacy USA division continues to witness comparable prescription growth as well as a robust retail prescription market.

                                Becton, Dickinson (BDX) a Step Closer to Bard Acquisition

                                by Zacks Equity Research

                                Becton, Dickinson and Company (BDX) gets FTC's nod for the acquisition of C. R. Bard.

                                  Merit Medical Deserves a Place in Your Portfolio: Here's Why

                                  by Zacks Equity Research

                                  A slew of bolt-on acquisitions leverages Merit Medical (MMSI) to drive inorganic growth.

                                    Becton, Dickinson Banks on Bard Buyout, Medical Unit Weak

                                    by Zacks Equity Research

                                    Becton, Dickinson (BDX) is steadily progressing with the acquisition of C. R. Bard. However, sluggishness in the Medical Segment is a headwind.

                                      Only 4 Dental Stocks to Buy Amid MedTech Regulatory Woes

                                      by Zacks Equity Research

                                      After a stellar five-year run on the bourse, the performance of the dental industry has taken a hit in the last two years.

                                        Dental Faces Regulatory Challenges: Only 5 Stocks to Pick

                                        by Zacks Equity Research

                                        Owing to the adversities in the medical universe, market watchers have adopted a bearish stance toward the dental space. These are the only five dental stocks that are expected to beat the ongoing MedTech gloom.

                                          AbbVie Inc. (ABBV) in Focus: Stock Moves 6.1% Higher

                                          by Zacks Equity Research

                                          AbbVie (ABBV) was a big mover last session, as the company saw its shares rise more than 6% on the day amid huge volumes.

                                            Weakness Seen in Aceto Corporation (ACET) Estimates: Should You Stay Away?

                                            by Zacks Equity Research

                                            Aceto Corporation (ACET) has witnessed a significant price decline in the past four weeks, and has seen negative earnings estimate revisions for the current quarter and year.

                                              Merit Medical Systems (MMSI) Worth a Look: Stock Gains 7.7%

                                              by Zacks Equity Research

                                              Merit Medical Systems, Inc. (MMSI) shares rose almost 8% in the last trading session.

                                                Merit Medical Embosphere Gets FDA de novo Classification

                                                by Zacks Equity Research

                                                Merit Medical Systems, Inc. (MMSI) recently announced the receipt of 513(f)(2) (de novo) classification for Embosphere Microspheres from the FDA to expand its indication in the prostatic artery embolization (PAE) space.

                                                  Merit Medical (MMSI) Closes 5.2M Follow-On Share Offering

                                                  by Zacks Equity Research

                                                  Merit Medical Systems, Inc. (MMSI) announced that it has closed its follow-on public offering of 5.2 million shares of common stock at $28.25 per share.